National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, Cincinnati, Ohio (Dr Schulte); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia (Dr Weissman, Dr Beezhold, Dr Radonovich); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 5555 Ridge Avenue, Cincinnati, Ohio (Dr Luckhaupt, Dr de Perio); National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 395 E Street SW, Washington, DC 20024 (Dr Piacentino, Hearl, Dr Howard).
Address correspondence to: Paul A. Schulte, PhD, National Institute for Occupational Safety and Health, Cincinnati, OH ([email protected]).
Schulte, Weissman, Luckhaupt, de Perio, Beezhold, Piacentino, Radonovich, Hearl, and Howard have no relationships/conditions/circumstances that present potential conflict of interest.
The JOEM editorial board and planners have no financial interest related to this research.
The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health. Mention of any company or product does not constitute endorsement by the National Institute for Occupational Safety and Health.
Clinical Significance: Pooled testing can substantially reduce the number of tests needed to screen a worker population for active infection with SARS-CoV-2 and the associated financial and opportunity costs for screening if the prevalence of the disease in a workplace is low.
